Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

How can genome editing improve human health? That's the theme researchers from the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) took to the latest Royal Institution Family Fun Day in London.

MRC WIMM researchers were enthusiastic participants of the Family Fun Day at the Royal Institution in London this past Saturday, part of a series of events around this year's Ri Christmas Lectures. The action packed day included talks, demonstrations and experiments exploring the science behind what makes each of us unique.

The MRC WIMM's contribution focused on how genome editing is helping biomedical research, and was part of the UKRI sponsored rooms, representing the Medical Research Council. Our colourful stand explored the science of genome editing, from the basics of the technique to its applications in medical research. The stand was originally developed for the MRC Festival of Medical Research 2018, but has since been taken to the Oxford Science and Ideas Festival and several local schools.

Read more (MRC WIMM website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.